Centre for Medical Radiation Science

Karolinska Institutet, KTH, Stockholm University, and Region Stockholm are establishing a joint center for medical radiation science. The center will bring together leading researchers, clinicians, and engineers to conduct interdisciplinary research and education, with the goal of strengthening Stockholm’s and Sweden’s position in medical radiation science and clinical radiation therapy.

A woman is treated with radiation in a hospital.
Radiation centre Photo: n/a,Getty Images/iStockphoto

Parties

Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University, and Region Stockholm are establishing a joint center for medical radiation science. By bringing together research, technology, and clinical practice, the center aims to develop the personalized radiation therapy of the future and strengthen Sweden’s position in precision cancer care.

Latest news

Meet our researchers

About us

Mission and Goals

The Center for Medical Radiation Science will bring together research, education, and innovation to develop the personalized radiation therapy of the future. The center is being established through a collaboration between Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University, and Region Stockholm. The brings together four strong partners with complementary expertise. Together, they create a unique environment where medical, natural science, and technical research, as well as clinical radiation therapy—including clinical trials—converge to develop the radiation therapy of the future for cancer care.

The goal is to strengthen Stockholm’s and Sweden’s position as leaders in precision radiation therapy.

Management

The Center for Medical Radiation Science is led through close collaboration among the four partners. The management team is responsible for strategic development, research priorities, and coordination of activities to ensure high scientific quality and long-term societal benefit.

The host institution for the center is the Department of Oncology and Pathology at Karolinska Institutet.

Partners

Karolinska Institutet

Karolinska Institutet contributes internationally leading medical research and education with a focus on translational and clinical radiation therapy. KI also conducts extensive research on basic cancer mechanisms relevant for the molecular response to radiation therapy. The university plays a central role in the development of new treatment methods and in the close link between research and clinical application.

KTH Royal Institute of Technology

KTH Royal Institute of Technologycontributes cutting-edge expertise in engineering, artificial intelligence, data analysis, and medical technology development. Through advanced technical solutions, new tools are being developed for diagnostics, treatment planning, and follow-up of radiation therapy.

Stockholm University

Stockholm University brings broad expertise in the natural sciences and mathematics, with a specialization in medical radiation physics. This enables the understanding, development, and optimization of future precision treatments in radiation therapy that utilize various types of radiation. Stockholm University also oversees the training of hospital physicists.

Region Stockholm

Region Stockholm is responsible for clinical operations and patient-centered research related to radiation therapy provided at departments at Karolinska University Hospital and Södersjukhuset, respectively. These sites conduct research in medical radiation physics, clinical radiation therapy, and translational biomarkers. Both departments also conduct a large number of clinical trials, many of which involve national and international collaborations. The healthcare system’s experience and infrastructure create the conditions for a more rapid translation of research findings into benefits for patients.

Research Areas

Initially, the center will focus on the following areas:

  • AI-based planning and evaluation of radiation therapy
  • Radiation therapy in combination with modern cancer drugs
  • Molecular radiation therapy

About radiation therapy

  • Region Stockholm is making a major investment in expanding capacity and further developing radiation therapy for cancer patients.
  • 50–60% of all cancer patients are treated with conventional external beam radiation therapy.
  • Radiation therapy can be administered with the intention of curing the disease or combined with chemotherapy, targeted therapy, and immunotherapy.

Funding

Building expertise for the future of cancer care

International experience shows that a shared research agenda is a crucial factor for success in building world-leading research environments in radiation therapy. In such an environment, young researchers can grow and develop innovative projects. Here, the Danish National Research Center for Radiation Therapy is highlighted as an example where an early investment in young researchers and doctoral students created the conditions for increased patient inclusion in clinical radiation therapy trials, strong scientific development with enhanced research capacity—all of which have resulted in greater international impact.

The Center for Medical Radiation Science aims to achieve the same in the Stockholm region and strengthen the expertise in research, innovation, and healthcare by new recruitments. Through collaboration between Karolinska Institutet, KTH, Stockholm University, and Region Stockholm, there is already a strong scientific and clinical environment with the capacity to mentor, train, and integrate the next generation of researchers in precision radiation therapy. However, targeted investments are needed to support younger researchers who can drive innovative projects and expand on the research agenda.

An investment in future expertise and patient benefit

A strategic investment in research and professional development within the center’s priority areas would strengthen the pool of preclinical, translational, and clinical researchers with the expertise to develop, evaluate, and implement new radiation therapy concepts and methods in cancer care.

Such an investment contributes both to scientific progress and to the long-term supply of expertise within the healthcare sector. By combining research and clinical practice, new research findings can benefit patients more quickly, while simultaneously strengthening Sweden’s appeal for international collaborations and research funding.

There is also an opportunity for funders to support specific research programs that can attract international cutting-edge expertise, strengthen future research leaders, and help build new research environments within the center’s priority areas.

Donors

Centre activities

Research

The center conducts interdisciplinary research in medical radiation science, with a focus on developing innovative, adaptive, and individualized radiation therapy approaches for cancer patients. The center has several focus areas where partners are already conducting cutting-edge research through national and international collaborations:

AI-based planning and evaluation of radiation therapy

Development of advanced AI and image analysis tools that can improve the planning, delivery, and follow-up of radiation therapy, as well as contribute to increased precision and better protection of normal tissue.

Clinical radiation therapy alone or in combination with modern cancer drugs

Clinical radiation therapy research and trials encompassing multiple techniques, including various types of external beam therapy for different tumors in adults and children using varying fractionation schedules, stereotactic radiation therapy (SR), stereotactic body radiation therapy (SBRT), high- or low-dose-rate brachytherapy, and particle therapies such as proton therapy. We are also conducting research on how radiation therapy best can be combined with immunotherapy or precision medicine from both a clinical and a biomarker perspectives. The aim is to tailor treatment to each patient and the biology of their tumor, with the goal of improving treatment efficacy and reducing side effects.

Molecular radiation therapy

Molecular radiotherapy or targeted radionuclide therapy is used to treat spread tumors/metastatic disease with radiation. Radionuclides are attached to targeting ligands, peptides, or monoclonal antibodies that specifically bind to proteins/receptors on tumor cells. In this way, radiation is delivered directly to the tumor while sparing normal tissue.

Education

The hospital physicist program.

External Collaboration

Social benefit

We want to contribute to

  • Developing more precise and adaptive radiation therapies for the benefit of cancer patients
  • Strengthening collaboration between universities and healthcare providers to accelerate the implementation of new research concepts into everyday clinical practice
  • Attracting younger researchers in radiation therapy and related disciplines to develop innovative, interdisciplinary radiation therapy concepts
  • Raising Stockholm’s profile as a leader in precision cancer care, where radiation therapy plays a key role